Stemedica Cell Technologies, Inc. Enters Into a Collaborative Agreement with Lumenis Ltd.

SAN DIEGO--(BUSINESS WIRE)--Stemedica Cell Technologies, Inc, (“Stemedica”), a leading manufacturer of best-in-class adult stem cells, has entered into a Collaboration Agreement with Lumenis, Ltd. (“Lumenis”), a global leader in medical laser technology. This collaboration agreement will focus on the implementation of a first-of-its-kind, comprehensive clinical study for the treatment of macular degeneration using Stemedica’s MCT™ (Multiple Cell Technology) adult stem cells and the Lumenis SRT™ Laser.

Back to news